The Relationship between Mojor Histocompatibility Complex Class I Molccules and Natural Killer Cells
The Relationship between Mojor Histocompatibility Complex Class I Molccules and Natural Killer Cells
批准号:
08670519
负责人:
KIURA Katsuyuki
金额:
$1.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1.NK cells were purified from a homozygous donor (A2402/, B0702/, Cw0702/) using a MiniMACS separation kit, and were immunized BALB/c mice three time biweekly. 2000 clones were screened using human NK cell line NK92 (A0301/A1101, B0702/B44031, Cw0702/Cw1602) by flow cytometry. We established 17 mAbs against the common antigens between human NK cells and NY cell line. Three mAbS(4-4-24-5.4-2-44-18.4-2-44-28) were IgG1 and reacted NK cells and a small part of T cells. mAb 4-4-24-5 partially inhibited the cytotoxicity of NK92 cells against K562 cells.2. Ly-49A is a member of the Ly-49 family of mouse NK cell receptors that inhibit cytotoxicity upon recognition of their ligands, the major histocompatibility complex (MHC) class I molecules on the target cell surface Although Ly-49A has an immunoreceptor tyrosine-based inhibition motif (ITIM) in its cytoplasmic tail. The mechanisms underlying its inhibitory function are poorly understood. We demonstrate here that antibody-mediated co-ligation of B cell receptor (BCR) with transfected Lv-49A molecule results in abrogation of BCR-induced Interleukin-2 (IL-2) secretion and substantial reduction in activation of Erk 1/2 and p38 MAP kinases in B cell line A20. Surprisingly. BCR-induced calcium mobilization was unaffected by cross-l inking of BCR with Ly-49A.Furthermore. substitution of the single tyrosine residue in the ITIM with phenylatanine did not result in a complete loss of the inhibitory function, as measu red by BCR-induced IL-2 secretion. Deletion of the N-terminal 37 amino acid peptide which includes the ITIM did abrogate the inhibitory activity. Co-immunoprecipitation experiments revealed that, upon induction of tyrosine phosphorylation. Ly-49A rccrnits tyrosine phosphatase SHP-1 but not inositol phosphatase SHIP, and that the tyrosine residue in the ITIM is critical for this interaction. These results suggest that Ly-49A utilizes two different inhibitory mechanisms : ITIM-dependent and ITIM-independent.
期刊论文(25)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ueoka H et al.: "A randomized trial of hybrid administration of cyclophosphamide. doxorubicin. and vincristine (CAV) /cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma :
Ueoka H 等人:“环磷酰胺、阿霉素和长春新碱 (CAV)/顺铂和依托泊苷 (PVP) 混合给药与 CAV-PVP 序贯给药治疗小细胞肺癌患者的随机试验:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
K.Kiura,S.Watarai H.Ueoka et al: "Analteration of ganglioside composition in cisplatin-resistant Lung cancer cell line" Anticancer Research. 18. 2957-2960 (1998)
K.Kiura,S.Watarai H.Ueoka 等:“顺铂耐药肺癌细胞系中神经节苷脂成分的改变”抗癌研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
W.Zeng, K.Kiura, I.NAKAMURA et al: "Murine NK cell allospecificity-1 is defined by inhibitory ligand" The Journal of Immunology. 156. 4651-4655 (1996)
W.Zeng、K.Kiura、I.NAKAMURA 等人:“小鼠 NK 细胞同种异体特异性 1 由抑制性配体定义”《免疫学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
W.Zheng, K.Kiura, I.Nakamura et al.: "Murine NK cell allospecificity-1 is defined by inhibitory ligands" The Journal of Immunology. 156. 4651-4655 (1996)
W.Zheng、K.Kiura、I.Nakamura 等人:“小鼠 NK 细胞同种异体特异性 1 由抑制性配体定义”《免疫学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
W-P Zheng,K Kiura I NAKAMURA et.al.: "Murine NK cell allospecificity-1 is defined by inhibitory ligands" The Journal of Immunology. 156. 4651-4665 (1996)
W-P Cheng、K Kiura I NAKAMURA 等人:“小鼠 NK 细胞同种异体特异性 1 由抑制性配体定义”《免疫学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 25 条
Basic study on combined modality therapy for advanced lung cancer harboring activated EGFR gene mutation
-
批准号:25670399
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2013
-
负责人:KIURA Katsuyuki
-
依托单位:
Basic and clinical study of EGFR gene mutation-positive lung cancer using a genetically modified mouse
-
批准号:23390221
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2011
-
负责人:KIURA Katsuyuki
-
依托单位:
A basic studyon malignant mesothelioma pathogenesis by internal radiation exposure of radium contained in the iron-containing protein
-
批准号:23659432
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:KIURA Katsuyuki
-
依托单位:
Chemoprevention of Lung Cancer using Epidermal Growth Factor Receptor Transgenic Mice
-
批准号:19590895
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:KIURA Katsuyuki
-
依托单位:
Chemoprevention of second primary cancer in the patients with lung cancer
-
批准号:16590746
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2004
-
负责人:KIURA Katsuyuki
-
依托单位:
Biological characteristics and genetic abnormalities in very, young patients with lung cancer (【less than or equal】30 years of age)
-
批准号:12670424
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2000
-
负责人:KIURA Katsuyuki
-
依托单位: